lapatinib has been researched along with quercetin 3-o-methyl ether in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (quercetin 3-o-methyl ether) | Trials (quercetin 3-o-methyl ether) | Recent Studies (post-2010) (quercetin 3-o-methyl ether) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 47 | 0 | 23 |
| Protein | Taxonomy | lapatinib (IC50) | quercetin 3-o-methyl ether (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 1.904 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 1.904 | |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 30.34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bode, AM; D'Alessio, A; De Luca, A; Dong, Z; Ericson, ME; Grubbs, C; Li, J; Lubet, RA; Normanno, N; Zhu, F | 1 |
1 other study(ies) available for lapatinib and quercetin 3-o-methyl ether
| Article | Year |
|---|---|
Quercetin-3-methyl ether inhibits lapatinib-sensitive and -resistant breast cancer cell growth by inducing G(2)/M arrest and apoptosis.
Topics: Apoptosis; Breast Neoplasms; Caspase 3; Caspase 7; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Cyclin B1; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; G2 Phase Cell Cycle Checkpoints; Humans; Lapatinib; M Phase Cell Cycle Checkpoints; MAP Kinase Signaling System; Poly(ADP-ribose) Polymerases; Protein Kinases; Proto-Oncogene Proteins c-akt; Quercetin; Quinazolines; Signal Transduction | 2013 |